Tekla Healthcare Investors Stock One Year Return
| HQH Stock | USD 15.90 0.16 1.02% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Tekla Healthcare's long-term financial health and intrinsic value.
Tekla | One Year Return | Build AI portfolio with Tekla Stock |
Tekla Healthcare Investors Company One Year Return Analysis
Tekla Healthcare's One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading.
More About One Year Return | All Equity Analysis
One Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Tekla One Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Tekla Healthcare is extremely important. It helps to project a fair market value of Tekla Stock properly, considering its historical fundamentals such as One Year Return. Since Tekla Healthcare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tekla Healthcare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tekla Healthcare's interrelated accounts and indicators.
Click cells to compare fundamentals
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Tekla Return On Tangible Assets
Return On Tangible Assets |
|
Based on the recorded statements, Tekla Healthcare Investors has an One Year Return of 0.0%. This indicator is about the same for the Capital Markets average (which is currently at 0.0) sector and about the same as Financials (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Tekla One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tekla Healthcare's direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tekla Healthcare could also be used in its relative valuation, which is a method of valuing Tekla Healthcare by comparing valuation metrics of similar companies.Tekla Healthcare is currently under evaluation in one year return category among its peers.
Tekla Healthcare Current Valuation Drivers
We derive many important indicators used in calculating different scores of Tekla Healthcare from analyzing Tekla Healthcare's financial statements. These drivers represent accounts that assess Tekla Healthcare's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Tekla Healthcare's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 894.2M | 1.0B | 1.1B | 819.3M | 836.7M | 1.0B | |
| Enterprise Value | 892.6M | 1.0B | 1.1B | 819.3M | 836.7M | 1.0B |
Tekla Healthcare ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tekla Healthcare's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tekla Healthcare's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Tekla Fundamentals
| Return On Equity | 0.0106 | ||||
| Return On Asset | -6.0E-4 | ||||
| Profit Margin | 1.02 % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 847.79 M | ||||
| Shares Outstanding | 53.86 M | ||||
| Shares Owned By Institutions | 22.16 % | ||||
| Number Of Shares Shorted | 58.31 K | ||||
| Price To Earning | 3.38 X | ||||
| Price To Book | 0.89 X | ||||
| Price To Sales | 83.14 X | ||||
| Revenue | 10.77 M | ||||
| Gross Profit | 10.2 M | ||||
| EBITDA | 56.33 M | ||||
| Net Income | 184.95 M | ||||
| Cash And Equivalents | 62 | ||||
| Total Debt | 1.4 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 17.66 X | ||||
| Cash Flow From Operations | (65.41 M) | ||||
| Short Ratio | 0.29 X | ||||
| Earnings Per Share | 0.13 X | ||||
| Beta | 0.71 | ||||
| Market Capitalization | 847.79 M | ||||
| Total Asset | 1.06 B | ||||
| Retained Earnings | 117.95 M | ||||
| Annual Yield | 0.15 % | ||||
| Five Year Return | 8.90 % | ||||
| Net Asset | 1.06 B | ||||
| Last Dividend Paid | 2.37 |
About Tekla Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tekla Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tekla Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tekla Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Tekla Healthcare Piotroski F Score and Tekla Healthcare Altman Z Score analysis. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 2.37 | Earnings Share 0.13 | Revenue Per Share | Quarterly Revenue Growth (0.11) |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.